Drug intelligence / Profile preview

SQJZ herbal mixture

Development stage: Phase 2
Lead developer: Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
Administration: Oral

Overview

SQJZ is a traditional Chinese medicine (TCM) herbal mixture developed by Dongzhimen Hospital, Beijing, for the treatment of non-motor symptoms (NMS) in Parkinson's disease. The formula is composed of several Chinese herb extracts, including *Rehmannia glutinosa* Libosch and *Astragalus membranaceus* (Fisch.) Bunge. It is specifically designed to address a range of NMS such as insomnia, constipation, and anxiety, which are common in Parkinson's patients. The mixture is currently being evaluated in multicenter, randomized, double-blind, placebo-controlled Phase 2 clinical trials to assess its efficacy and safety, with primary outcomes measured using the Non-Motor Symptom Scale (NMSS).

Other names: SQJZ herbal formulaSQJZ mixture

Beyond the preview

Go deeper on SQJZ herbal mixture.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SQJZ herbal mixture.

Explore the full profile